In January, the results of a long-term study on the effects of minors using cross-sex hormones were made public. The hormones prescribed to the participants were described as “gender-affirming hormones”—with such treatment regimens also referred to in the literature as “gender-affirming care” or “transgender medicine.”
Some 315 people between the ages of 12 and 20 were monitored for a period of two years to examine their “physical and psychosocial outcomes” after the administration of either testosterone or estradiol, a form of estrogen.
Funded by the National Institutes of Health (NIH), the study concluded that the results were ultimately positive because the young participants, who were described as “transgender and nonbinary,” felt and looked more like the opposite sex….